TerminatedPhase 2NCT02644525
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
Studying Loiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Elise M O'Connell, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- Imatinib Mesylate(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2019 – 2021
Study locations (1)
- Centre de Recherche sur les Filarioses et Autres Maladies Tropicales, Mbalmayo, Cameroon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02644525 on ClinicalTrials.govOther trials for Loiasis
Additional recruiting or active studies for the same condition.